2017
DOI: 10.1590/s1518-8787.2017051006416
|View full text |Cite
|
Sign up to set email alerts
|

Cholesterol and prevention of atherosclerotic events: limits of a new frontier

Abstract: Control of atherosclerotic cardiovascular disease – a highly prevalent condition and one of the main causes of mortality in Brazil and worldwide – is a recurrent subject of great interest for public health. Recently, three new guidelines on dyslipidemia and atherosclerosis prevention have been published. The close release of these important publications is a good opportunity for comparison: the Brazilian model has greater sensitivity, the English model does not work with risk stratification, and the American m… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 20 publications
0
1
0
1
Order By: Relevance
“…In regard to clinical aspects, the higher prevalence of DM ( p = 0.003) and dyslipidemia in patients with RH in relation to patients with hypertension suggests a higher cardiovascular risk (CVR) related to RH. 35 , 36 Furthermore, the use of statins was more common among patients with RH, which may also be related to the elevated CVR and renal dysfunction risk in this group. 37 Although greater in the RH group, the difference between the prevalence of dyslipidemia in the two groups was lower than the difference found between the percentage of statin use.…”
Section: Discussionmentioning
confidence: 97%
“…In regard to clinical aspects, the higher prevalence of DM ( p = 0.003) and dyslipidemia in patients with RH in relation to patients with hypertension suggests a higher cardiovascular risk (CVR) related to RH. 35 , 36 Furthermore, the use of statins was more common among patients with RH, which may also be related to the elevated CVR and renal dysfunction risk in this group. 37 Although greater in the RH group, the difference between the prevalence of dyslipidemia in the two groups was lower than the difference found between the percentage of statin use.…”
Section: Discussionmentioning
confidence: 97%
“…Neste estudo pode-se observar a maior prevalência de HDL-C baixo no sexo feminino, correlacionando com o estudo de Oliveira, et al 16 , que apresentou 91,38% de mulheres com HDL-C baixo. As concentrações séricas do HDL-C estão inversamente relacionadas ao risco de doença aterosclerótica, esta lipoproteína atua no transporte reverso do colesterol, como também exerce várias atividades como antioxidantes, anti-inflamatórias, vasodilatadoras entre outras 21 .…”
Section: Discussionunclassified